Skip to main content
OpenTrials
Completed

NCT Number: NCT01321424

Diurnal Variation in Tear Osmolarity

The purpose of this study is to measure the change in Tear Osmolarity during the course of the day to support clinical diagnosis of aqueous deficiency or meibomian gland disease and differentiate between the two forms of dry eye.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ophthalmic Consultants of Connecticut, Fairfield, Connecticut, United States

Loading trial locations.

About this study

The premise of this study is that dry eye disease, specifically tear osmolarity, changes during the course of the day based on the etiology of the dry eye and that aqueous-deficiency dry eye will worsen during the course of the day while meibomian gland deficiency will stabilize or possibly even improve during the course of the day.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy males and females ≥ 18 years old
  • Negative urine pregnancy results for females of childbearing potential
  • Able to read and sign an informed consent form and show willingness to comply with the study protocol visits and procedures
  • Has 20/40 BCVA or better in at least one eye
  • Does not currently wear contact lenses
  • For Aqueous-Deficiency Group:
  • Has symptoms of Dry Eye
  • Schirmer testing ≤ 10 mm
  • Tear Break Up Time ≤ 8 seconds
  • Conjunctival staining ≥ 1+
  • Meibomian gland inspissations ≤ 1+
  • No lid thickening, lid erythema, or thickened, turbid meibomian gland secretions
  • For Meibomian Gland Disease Group:
  • Has symptoms of Dry Eye
  • Schirmer testing ≥ 10 mm
  • Tear Break Up Time ≤ 8 seconds
  • Conjunctival staining ≥ 1+
  • Meibomian gland inspissations ≥ 2+
  • For Normal Group:
  • Has no symptoms of Dry Eye
  • Schirmer testing > 10 mm
  • Tear Break Up Time > 8 seconds
  • No or trace Conjunctival staining
  • No Meibomian gland inspissations

Exclusion criteria

  • Any topical medication within the last three months, except for artificial tears
  • Unable to discontinue use of artificial tears during the course of the day for Visit 2
  • Any Systemic disease, which in the opinion of the Investigator, may affect ocular health or confound study results
  • Any active ocular disease other than Dry Eye Disease, Meibomian Gland Disease or Sjogren's Syndrome, which in the opinion of the Investigator, may affect ocular health or confound study results
  • Clinically significant lid or conjunctival abnormalities, neovascularization, corneal scars or corneal opacities
  • Clinically significant limbal or bulbar injection, or corneal staining not due to DES
  • Has worn hard or rigid gas permeable contact lenses within 1 year
  • Has worn soft contact lenses within 1 week
  • Has had eye surgery or an eye injury within 6 months
  • Positive urine pregnancy results for females of childbearing potential
  • Any changes in current medication within 30 days of Visit 2 or anticipated change during course of study, which in the opinion of the Investigator may confound study results

Treatment and study plan

Primary outcomes

  1. The measured difference in Tear Osmolarity during the course of the day to support clinical diagnosis and differentiate between aqueous-deficiency and meibomian gland disease.

    Time frame: 1 Day (AM and PM Diurnal)

Secondary outcomes

  1. Ocular Improvement

    Time frame: 31 Days

    Improvement in Ocular Surface Disease Index, Best Corrected Visual Acuity, Uncorrected Visual Acuity, Slit Lamp Exam, Schirmer test, Lissamine green conjunctival staining, Fluorescein corneal staining and Tear Break Up Time

Sponsors and collaborators

Lead sponsor

Ophthalmic Consultants of Long Island

Other

Collaborators

  • Allergan

Registry information

Official study title

Investigator Sponsored, Pilot Study to Assess the Diurnal Variation in Tear Osmolarity as a Predictor of Dry Eye Disease Etiology

Important dates

Study start
2011
Primary completion
2016
Study completion
2016
First posted
Mar 23, 2011
Registry last updated
Apr 25, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.